ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,784Medicare Part D Prescriptions Filled, Including Refills

Rank: 14 out of 224

$453K Total Retail Price of All Prescriptions

Rank: 18 out of 224

360 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
48% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Vermont
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 360 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

10% of this provider’s 360 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

2% of this provider’s 5,763 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $63 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Vermont
SIMVASTATIN 385 294 1 1
OMEPRAZOLE 313 225 2 3
LEVOTHYROXINE SODIUM 273 185 3 4
METOPROLOL TARTRATE 264 245 4 7
LISINOPRIL 236 178 5 2
CITALOPRAM HBR 223 159 6 15
AMLODIPINE BESYLATE 188 158 7 8
FUROSEMIDE 186 146 8 5
METFORMIN HCL 164 148 9 9
WARFARIN SODIUM 156 82 10 10
HYDROCHLOROTHIAZIDE 144 129 11 6
METOPROLOL SUCCINATE 134 85 12 11
ATORVASTATIN CALCIUM 122 100 13 16
PREDNISONE 116 84 14 28
TRAMADOL HCL 108 86 15 18
ZOLPIDEM TARTRATE 87 75 16 22
HYDROCODONE-ACETAMINOPHEN 85 78 S3 17 12
GABAPENTIN 81 45 18 14
FLUTICASONE PROPIONATE 74 53 19 45
ALLOPURINOL 70 64 20 40
PRAVASTATIN SODIUM 69 41 21 21
ALENDRONATE SODIUM 69 69 21 39
FENTANYL 69 31 S2 21 49
NEXIUM 66 40 24 34
TRAZODONE HCL 66 51 24 20
TAMSULOSIN HCL 65 62 26 30
SERTRALINE HCL 64 49 27 17
GLYBURIDE 63 49 R 28 61
SPIRIVA 61 56 29 32
OXYCODONE HCL 56 31 S2 30 25
LISINOPRIL-HYDROCHLOROTHIAZIDE 56 56 30 35
SYNTHROID 55 55 32 74
PANTOPRAZOLE SODIUM 54 39 33 27
PROAIR HFA 52 41 34 26
CEFUROXIME 51 32 35 174
ENALAPRIL MALEATE 50 46 36 42
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 10, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.